/GSAC
GSAC Stock - GelStat Corporation
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
44
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.38
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.1
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GSAC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.97
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $349,730 | $149,527 | $2,333 | $7,022 | $3,950 |
| Gross Profit | $233,834 | $130,582 | $-408,000 | $-173,000 | $-130,628 |
| Gross Margin | 66.9% | 87.3% | -17488.2% | -2463.7% | -3307.0% |
| Operating Income | $-281,000 | $-165,827 | $-602,000 | $-313,000 | $-177,547 |
| Net Income | $-373,000 | $-210,111 | $-761,000 | $-475,000 | $-177,838 |
| Net Margin | -106.7% | -140.5% | -32618.9% | -6764.5% | -4502.2% |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Company Overview
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation is headquartered in Palm City, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GSACBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2008
EPS Surprise History
Q4 06
No data
Q1 07
No data
Q2 07
No data
Q3 07
No data
Q4 07
No data
Q1 08
No data
Q2 08
No data
Q3 08
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2015 | Apr 16, 2015 | — | — | — | — |
Q4 2014 | Nov 17, 2014 | — | — | — | — |
Q3 2008 | Sep 30, 2008 | — | $-0.00 | — | — |
Q2 2008 | Jun 30, 2008 | — | $-0.01 | — | — |
Q1 2008 | Mar 31, 2008 | — | $-0.01 | — | — |
Q4 2007 | Dec 31, 2007 | — | $-0.01 | — | — |
Q3 2007 | Sep 30, 2007 | — | $-0.01 | — | — |
Q2 2007 | Jun 30, 2007 | — | $-0.01 | — | — |
Q1 2007 | Mar 31, 2007 | — | $-0.01 | — | — |
Q4 2006 | Dec 31, 2006 | — | $-0.02 | — | — |
Q3 2006 | Sep 30, 2006 | — | $-0.02 | — | — |
Q2 2006 | Jun 30, 2006 | — | $-0.02 | — | — |
Q1 2006 | Mar 31, 2006 | — | $-0.04 | — | — |
Q4 2005 | Dec 31, 2005 | — | $-0.10 | — | — |
Q3 2005 | Sep 30, 2005 | — | $-0.07 | — | — |
Q2 2005 | Jun 30, 2005 | — | $-0.11 | — | — |
Q1 2005 | Mar 31, 2005 | — | $-0.08 | — | — |
Q4 2004 | Dec 31, 2004 | — | $-0.14 | — | — |
Q3 2004 | Sep 30, 2004 | — | $-0.22 | — | — |
Q2 2004 | Jun 30, 2004 | — | $-0.10 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GSAC
What is GSAC's current stock price?
GelStat Corporation (GSAC) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for GSAC?
No analyst price targets are currently available for this stock.
What sector is GelStat Corporation in?
GelStat Corporation operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is GSAC's market cap?
GelStat Corporation has a market capitalization of $0.00 billion, making it a small-cap company.
Does GSAC pay dividends?
No, GelStat Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAOXG
Aoxing Pharmaceutical Company, Inc.
$0.00
Mkt Cap: $0.0B
CWWBF
Plant-Based Investment Corp.
$0.00
Mkt Cap: $0.0B
FFNTF
4Front Ventures Corp.
$0.00
Mkt Cap: $0.0B
GPFT
Grapefruit USA, Inc.
$0.00
Mkt Cap: $0.0B
LRSV
Link Reservations Inc.
$0.00
Mkt Cap: $0.0B
PEMTF
Thoughtful Brands Inc.
$0.00
Mkt Cap: $0.0B
PZOO
Pazoo, Inc.
$0.00
Mkt Cap: $0.0B
RLBD
Real Brands, Inc.
$0.00
Mkt Cap: $0.0B
SFLM
SFLMaven Corp.
$0.00
Mkt Cap: $0.0B
VDRM
ViaDerma, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to GSAC for comparison